FDA reviews psychiatric side effects of Chantix

WASHINGTON (AP) — The Food and Drug Administration announced Friday it will hold a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer's anti-smoking drug Chantix.



via Health News Headlines - Yahoo News http://ift.tt/1gZrgoj